Zurich Cantonal Bank
AVXL icon

Zurich Cantonal Bank’s Anavex Life Sciences AVXL Stock Holding History

Zurich Cantonal Bank’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-64,947
Closed -$231K – 2661
2025
Q4 		$231K Buy
+64,947
New +$398K ﹤0.01% 2174

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Zurich Cantonal Bank's AVXL Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Anavex Life Sciences (AVXL) in Q1 2026: 19 shares worth $58. The stake represents ﹤0.01% of the portfolio and ranks #2525 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in AVXL as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in AVXL in Q2 2021 and has held it in 19 quarters since. The position peaked at $407K in Q2 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Zurich Cantonal Bank held 19 shares of Anavex Life Sciences worth $58 as of Q1 2026.
  • Anavex Life Sciences was a new Zurich Cantonal Bank position in Q1 2026.
  • Anavex Life Sciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2525 holding.
  • Zurich Cantonal Bank first reported a position in Anavex Life Sciences in Q2 2021 and has held it in 19 quarters since.
  • Zurich Cantonal Bank's Anavex Life Sciences position peaked at $407K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.